Phase I Pharmacokinetic Study (SALBLOCK)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The objective of the study is to assess the extent to which the charcoal prevents the absorption of salmeterol and fluticasone via the GI tract. The assessment will be based on comparing the pharmacokinetic parameter area under the concentration-time curve (AUCt).
Epistemonikos ID: beef828d34cc510f7e3d7fb815308409c96341a6
First added on: May 10, 2024